TLSI Valuation

TriSalus Life Sciences Inc

Add to Watchlist

Advanced Chart

4.600

-0.12(-2.542%)1D

Overview
Forecast
Valuation
Earnings

TLSI Relative Valuation

TLSI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TLSI is overvalued; if below, it's undervalued.

Historical Valuation

TriSalus Life Sciences Inc (TLSI) is now in the Fair zone, suggesting that its current forward PS ratio of 3.45 is considered Fairly compared with the five-year average of -2.94. The fair price of TriSalus Life Sciences Inc (TLSI) is between 4.34 to 5.37 according to relative valuation methord.

Relative Value

Fair Zone

4.34-5.37

Current Price：4.60

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

-4.32

P/B

Median3y

-2.61

Median5y

-1.95

-19.88

FCF Yield

Median3y

-25.65

Median5y

-18.71

Competitors Valuation Multiple

The average P/S ratio for TLSI's competitors is 2.62, providing a benchmark for relative valuation. TriSalus Life Sciences Inc Corp (TLSI) exhibits a P/S ratio of 3.45, which is 31.69% above the industry average. Given its robust revenue growth of 41.97%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

TLSI.O

TriSalus Life Sciences Inc

3.45

Average P/S: 2.62

41.97%